Drug Shortage Report for NAT-PREGABALIN
| Report ID | 192650 |
| Drug Identification Number | 02494892 |
| Brand name | NAT-PREGABALIN |
| Common or Proper name | Pregabalin |
| Company Name | NATCO PHARMA (CANADA) INC |
| Market Status | MARKETED |
| Active Ingredient(s) | PREGABALIN |
| Strength(s) | 225MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL |
| Packaging size | Bottles of 100s |
| ATC code | N02BF |
| ATC description | |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2023-05-17 |
| Estimated end date | 2025-05-16 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-02-02 |
| Company comments | Long Term Back Order |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2000 ARGENTIA ROAD, PLAZA 1, SUITE 200 MISSISSAUGA, ONTARIO CANADA L5N 1P7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2024-02-02 | French | Compare |
| v7 | 2024-02-02 | English | Compare |
| v6 | 2023-05-18 | English | Compare |
| v5 | 2023-05-17 | French | Compare |
| v4 | 2023-05-17 | English | Compare |
| v3 | 2023-05-17 | French | Compare |
| v2 | 2023-05-17 | English | Compare |
| v1 | 2023-05-17 | English | Compare |
Showing 1 to 8 of 8